Jeff Vacirca: We couldn’t be more proud to support Thyme Care with their Series C announcement

Jeff Vacirca, CEO at New York Cancer and Blood Specialists, shared a post on LinkedIn:

”Cancer is costly and complex to manage, and while there have been incredible feats of scientific and medical breakthroughs, little innovation to the cancer care experience has been made until now. Thyme Care is transforming the experience and reducing costs for cancer patients across the care continuum, and we couldn’t be more proud to support them with their Series C announcement. Read more here.”

Source: Jeff Vacirca/LinkedIn